Employer GLP-1 coverage questions to ask HR in 2026

Request the current drug list (formulary) and ask HR which plan option you are enrolled in, since formularies can differ by option. Confirm the exact product name and form, because coverage can vary between injections and pills. If you’re comparing newer options, ask whether Wegovy (including the pill and injection forms), Foundayo (orforglipron), and Zepbound KwikPen appear on the formulary. Ask HR to share the PBM (pharmacy benefit manager) name and the link or PDF where the formulary is posted.

Ask whether your plan requires prior authorization (PA) for each GLP-1 and whether there are step therapy rules (try one medicine before another). Ask what clinical information the PA typically requests, and how often re-authorization is required. If your plan distinguishes “weight management” vs “type 2 diabetes” use, ask how they categorize each medication under your benefits. HR can’t make medical decisions, but they can tell you the administrative rules that often cause delays.

Ask for the cost-sharing details that apply to your exact plan: copay vs coinsurance, and whether your deductible must be met first. Ask whether GLP-1s fall under a special “preferred/non-preferred” tier and whether different forms (like a pill vs pen) price differently. If you use manufacturer programs, ask if the plan has a copay accumulator or maximizer policy that changes how coupons apply. Remind HR that prices and programs change often, and confirm the most current information through the plan, PBM, or your pharmacist.

Many denials happen because a prescription is filled at the “wrong” pharmacy. Ask whether your plan requires mail order after a certain number of fills, or restricts GLP-1s to specialty pharmacies. If you’re interested in manufacturer direct options, ask whether the plan coordinates with channels like LillyDirect (for Foundayo) or NovoCare pathways for Novo Nordisk products, or if you must use the plan’s pharmacy network. If you travel often, ask about out-of-state fills and early refill rules.

If you currently use a compounded version, ask HR whether your plan reimburses or covers any compounded GLP-1 prescriptions (many plans treat them differently from FDA-approved products). Ask how the plan handles claims for compounding pharmacies and whether receipts can be submitted for reimbursement. Keep the conversation factual and administrative: you are not asking HR for medical guidance, only whether the benefit covers it. For safety and suitability questions, route those to your prescribing clinician and pharmacist.

Ask HR what happens if a covered GLP-1 is removed from the formulary or moved to a higher tier during the plan year. Ask whether your plan offers a formulary exception, continuity-of-care process, or an appeals pathway, and what documentation is needed. If you are Medicare-eligible, ask whether your situation fits regular Part D coverage or whether a temporary CMS demonstration (the Medicare GLP-1 Bridge, running July 1, 2026 through Dec 31, 2027) could apply to you—HR can point you to plan resources, but eligibility and prior authorization are handled through the Part D plan. If you are paying cash at times, ask whether the plan provides any price-transparency tools or directs members to federal resources like TrumpRx.gov, and confirm current pricing directly with the manufacturer because amounts can change.